Skip to main content
. 2021 May 27;13(11):2638. doi: 10.3390/cancers13112638
5-FU 5-fluorouracil
APC Antigen presenting cell
APM Antigen presenting machinery
B2M β 2 microglobulin
BMMR-D Biallelic mismatch repair deficiency syndrome
CCL Chemokine (cc motif) ligand
cGAMP Cyclic guanosine monophosphate-adenosine monophosphate
c-GAS Cyclic GMP-AMP synthase
CIMP CpG island methylator phenotype
CMS Consensus molecular subtype
CN-LOH Copy-neutral loss of heterozygosity
CPIs Checkpoint inhibitors
CRC Colorectal cancer
CSF1-R Colony stimulating factor 1 receptor
CTLA4 Cytotoxic T-lymphocyte antigen 4
CTNNB1 β -catenin
CXC Chemokine (cxc motif)
CXCL Chemokine (cxc motif) ligand
DBS Double base substitution
DC Dendritic cell
DCR Disease control rate
DFCI Dana Farber Cancer Institute
DOR Duration of response
ENPP1 Ectonucleotide pyrophosphatase/phosphodiesterase 1
ERP57 Endoplasmic reticulum protein 57
EXO 1 Exonuclease 1
FOXP 3 Forkhead box 3
FS Frameshift
GATA3 GATA binding protein 3
GROα Growth regulated protein α
GSK3B Glycogen synthase kinase 3 beta
HLA Human leukocyte antigen
HNPCC Hereditary non-polyposis colorectal cancer
HPV Human Papilloma Virus
ICOS Inducible T-cell costimulator
IDO Indoleamine 2,3-dioxygenase
IL- Interleukin-
IL1RA IL-1 receptor agonist
IN/DEL Insertion/deletion
INF Interferon
IRF3 Interferon regulatory factor 3
JAK Janus kinases
LAG3 Lymphocyte activation gene 3
M1 M1-like macrophages
M2 M2-like macrophages
mCRC Metastatic CRC
MDSC Myeloid derived suppressor cells
MGMT O6-methylguanine-DNA methyltransferase
MHC Major histocompatibility complex
MLH1 MutL homolog 1
MMR Mismatch repair
MMRd Mismatch repair deficient
MMRp Mismatch repair proficient
mPFS Median progression free survival
MSH2 MutS homolog 2
MSH6 MutS homolog 6
MSI Microsatellite instability
MSS Microsatellite stable
NFKB Nuclear factor Kappa-ligand-chain-enhancer of activated B cells
NGS Next generation sequencing
NK Natural killer
NKG2D Natural killer group 2 member D
NLRC5 NLR family CARD domain containing 5
NSCLC Non-small cell lung cancer
ORR Objective response rate
OS Overall survival
PD-1 Programmed cell death protein 1
PD-L1 Programmed cell death protein ligand 1
PFS Progression free survival
PMS2 PMS1 homolog 2
POLD1 Polymerase delta 1
POLE Polymerase epsilon
RAE1 Retinoic acid early transcript 1 ligand
RCC Renal cell carcinoma
RFX5 Regulatory factor X5
ROS Reactive oxygen species
RPA Replication protein A
SBS Single base substitution
SNVs Single nucleotide variants
STAT Signal transducer and activator of transcription
STING Stimulator of interferon gene
TAM Tumor associated macrophages
TAP Transporter associated with antigen processing
TCF4 T cell factor 4
TCGA The Cancer Genome Atlas
TCR T cell receptor
Tfh T follicular helper
TGFBR2 TGF-β receptor 2
TGF-β Transforming growth factor β
Th1 T-helper type 1
TIM3 T-cell immunoglobulin and mucin domain-3
TMB Tumor mutational burden
Treg Regulatory T cells
VEGF Vascular endothelial growth factor
VISTA V-domain Ig suppressor of T cell activation